New obesity injection tested for safety and weight loss
NCT ID NCT06350812
Summary
This early-stage study tested a new injection called PB-119 in Chinese adults with obesity. The main goal was to check if the injection was safe and how the body processed it. Researchers also looked to see if it helped people lose weight over a 20-week treatment period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Third XIANGYA Hospital of Central South University
Changsha, Hunan, 410013, China
Conditions
Explore the condition pages connected to this study.